{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:39:33Z","timestamp":1793104773288,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Take Part Foundation"},{"name":"Westmead Research Hub User Access Scheme"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1143901"],"award-info":[{"award-number":["APP1143901"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1121651"],"award-info":[{"award-number":["GNT1121651"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Biallelic variants in\n                    <jats:italic>PYROXD1<\/jats:italic>\n                    are associated with a life limiting muscle and connective tissue disorder characterised by generalised muscle weakness, breathing and feeding difficulties, distal laxity, hypernasal speech, blue sclera and osteopenia.\n                    <jats:italic>PYROXD1<\/jats:italic>\n                    encodes an oxidoreductase implicated in mitochondrial function and tRNA ligase activity. Herein we present the first comprehensive suite of mouse models designed to elucidate PYROXD1 redox functions and the underlying pathogenetic basis for\n                    <jats:italic>PYROXD1<\/jats:italic>\n                    disorders. A LacZ reporter strain reveals ubiquitous expression of\n                    <jats:italic>Pyroxd1<\/jats:italic>\n                    , particularly in the developing head, eye, heart and skin. Complete knockout (KO) of\n                    <jats:italic>Pyroxd1<\/jats:italic>\n                    resulted in embryonic lethality between ED4.5\u2013E9.5, suggesting Pyroxd1 performs a unique function during embryogenesis that cannot be substituted by other redox enzymes. Skeletal muscle tissue-specific KO, or stage-specific tamoxifen-induced KO during gestation or post-weaning, were viable but not sustainable models. Tamoxifen-inducible KO cell lines derived from these models provide valuable tools for dissecting Pyroxd1 function. Homozygous mice harbouring the recurrent human variant NM_024854.5:c.464A\u2009&gt;\u2009G;p.(N155S), termed\n                    <jats:italic>Pyroxd1<\/jats:italic>\n                    <jats:sub>N155S<\/jats:sub>\n                    , phenocopied a severe PYROXD1 disorder, presenting from\u2009~\u200910\u00a0weeks of age with a progressive myopathy, myofibrillar disorganisation, decreased contractile strength, muscle hypotrophy and osteopenia. Conversely, homozygous\n                    <jats:italic>Pyroxd1<\/jats:italic>\n                    <jats:sub>N155G<\/jats:sub>\n                    mice, created incidentally during CRISPR editing, were phenotypically normal and provide an important benign control. Proteomic analyses reveal distinct molecular signatures between acute\n                    <jats:italic>Pyroxd1<\/jats:italic>\n                    KO and\n                    <jats:italic>Pyroxd1<\/jats:italic>\n                    <jats:sub>N155S<\/jats:sub>\n                    models\n                    <jats:sub>,<\/jats:sub>\n                    highlighting differential effects of complete loss-of-function (KO) compared to partial enzymatic activity (N155S). Pyroxd1 activity is critical for numerous cell essential processes, including protein biosynthesis and turnover, tRNA ligase complex activity and the unfolded protein response, mitochondrial respiratory chain function (especially complex 1), with an implicated broader role in the exon-ligation step of pre-mRNA splicing. Together, these murine\n                    <jats:italic>Pyroxd1<\/jats:italic>\n                    models establish an enabling platform for gaining mechanistic insight and guiding the path of future therapeutic development for PYROXD1 disorders.\n                  <\/jats:p>","DOI":"10.1186\/s40478-026-02259-1","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:06:24Z","timestamp":1772463984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pyroxd1 is essential for murine viability with the homozygous N155S recurrent variant linked to myopathy, muscle hypotrophy and osteopenia"],"prefix":"10.1186","volume":"14","author":[{"given":"Frances J.","family":"Evesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Dziaduch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Yasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonit","family":"Kiriaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignatius","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kettle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Katrin","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse R.","family":"Wark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bryan","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick P. L.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Houweling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A.","family":"Lemcket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra T.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"12","key":"2259_CR1","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.molcel.2021.04.007","volume":"81","author":"I Asanovi\u0107","year":"2021","unstructured":"Asanovi\u0107 I, Strandback E, Kroupova A et al (2021) The oxidoreductase PYROXD1 uses NAD(P)+ as an antioxidant to sustain tRNA ligase activity in pre-tRNA splicing and unfolded protein response. Mol Cell 81(12):2520-2532.e16. https:\/\/doi.org\/10.1016\/j.molcel.2021.04.007","journal-title":"Mol Cell"},{"issue":"11","key":"2259_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1152\/physiolgenomics.00036.2018","volume":"50","author":"M Saha","year":"2018","unstructured":"Saha M, Reddy HM, Salih MA et al (2018) Impact of PYROXD1 deficiency on cellular respiration and correlations with genetic analyses of limb-girdle muscular dystrophy in Saudi Arabia and Sudan. Physiol Genomics 50(11):929\u2013939. https:\/\/doi.org\/10.1152\/physiolgenomics.00036.2018","journal-title":"Physiol Genomics"},{"issue":"5","key":"2259_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/J.AJHG.2016.09.005","volume":"99","author":"GL O\u2019Grady","year":"2016","unstructured":"O\u2019Grady GL, Best HA, Sztal TE et al (2016) Variants in the oxidoreductase PYROXD1 cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. Am J Hum Genet 99(5):1086\u20131105. https:\/\/doi.org\/10.1016\/J.AJHG.2016.09.005","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2259_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/BCR-2024-259907","volume":"17","author":"MS D\u2019Costa","year":"2024","unstructured":"D\u2019Costa MS, Bugiardini E, Merve A, Morrow JM (2024) PYROXD1-associated myopathy. BMJ Case Rep CP 17(3):e259907. https:\/\/doi.org\/10.1136\/BCR-2024-259907","journal-title":"BMJ Case Rep CP"},{"issue":"1","key":"2259_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0781-8","volume":"7","author":"X Lornage","year":"2019","unstructured":"Lornage X, Schartner V, Balbueno I et al (2019) Clinical, histological, and genetic characterization of PYROXD1-related myopathy. Acta Neuropathol Commun 7(1):138. https:\/\/doi.org\/10.1186\/s40478-019-0781-8","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"2259_CR6","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/AJMG.A.62148","volume":"185","author":"HS Daimag\u00fcler","year":"2021","unstructured":"Daimag\u00fcler HS, Akpulat U, \u00d6zdemir \u00d6 et al (2021) Clinical and genetic characterization of PYROXD1-related myopathy patients from Turkey. Am J Med Genet A 185(6):1678\u20131690. https:\/\/doi.org\/10.1002\/AJMG.A.62148","journal-title":"Am J Med Genet A"},{"issue":"3","key":"2259_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/hmg\/ddad035","volume":"26","author":"FJ Evesson","year":"2023","unstructured":"Evesson FJ, Dziaduch G, Bryen SJ et al (2023) PYROXD1 variants cause an overlapping myopathy and connective tissue disorder. Hum Mol Genet 26(3):312\u2013318. https:\/\/doi.org\/10.1093\/hmg\/ddad035","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2259_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/neup.12641","volume":"40","author":"JD Woods","year":"2020","unstructured":"Woods JD, Khanlou N, Lee H et al (2020) Myopathy associated with homozygous PYROXD1 pathogenic variants detected by genome sequencing. Neuropathology 40(3):302\u2013307. https:\/\/doi.org\/10.1111\/neup.12641","journal-title":"Neuropathology"},{"issue":"2","key":"2259_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00415-018-9137-8","volume":"266","author":"MT Sainio","year":"2019","unstructured":"Sainio MT, V\u00e4lipakka S, Rinaldi B et al (2019) Recessive PYROXD1 mutations cause adult-onset limb-girdle-type muscular dystrophy. J Neurol 266(2):353\u2013360. https:\/\/doi.org\/10.1007\/s00415-018-9137-8","journal-title":"J Neurol"},{"issue":"2","key":"2259_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/22143602241301635\/SUPPL_FILE\/SJ-DOCX-1-JND-10.1177_22143602241301635.DOCX","volume":"12","author":"D Baskar","year":"2025","unstructured":"Baskar D, Thomas A, Boddu VK et al (2025) A rare case of myopathy with fatigability due to PYROXD1 variation. J Neuromuscul Dis 12(2):293\u2013300. https:\/\/doi.org\/10.1177\/22143602241301635\/SUPPL_FILE\/SJ-DOCX-1-JND-10.1177_22143602241301635.DOCX","journal-title":"J Neuromuscul Dis"},{"issue":"6264","key":"2259_CR11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.aac7557","volume":"350","author":"VA Blomen","year":"2015","unstructured":"Blomen VA, Majek P, Jae LT et al (2015) Gene essentiality and synthetic lethality in haploid human cells. Science 350(6264):1092\u20131096. https:\/\/doi.org\/10.1126\/science.aac7557","journal-title":"Science"},{"key":"2259_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1246981","author":"T Wang","year":"2014","unstructured":"Wang T, Wei JJ, Sabatini DM, Lander ES (2014) Genetic screens in human cells using the CRISPR\/Cas9 system. Science. https:\/\/doi.org\/10.1126\/science.1246981","journal-title":"Science"},{"key":"2259_CR13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","volume":"163","author":"T Hart","year":"2015","unstructured":"Hart T, Chandrashekhar M, Aregger M et al (2015) High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163:1515\u20131526. https:\/\/doi.org\/10.1016\/j.cell.2015.11.015","journal-title":"Cell"},{"key":"2259_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/S41594-025-01516-6","author":"L Loeff","year":"2025","unstructured":"Loeff L, Kroupova A, Asanovi\u0107 I et al (2025) Mechanistic basis for PYROXD1-mediated protection of the human tRNA ligase complex against oxidative inactivation. Nat Struct Mol Biol. https:\/\/doi.org\/10.1038\/S41594-025-01516-6","journal-title":"Nat Struct Mol Biol"},{"issue":"18","key":"2259_CR15","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1242\/DEV.033183","volume":"136","author":"W Tadros","year":"2009","unstructured":"Tadros W, Lipshitz HD (2009) The maternal-to-zygotic transition: a play in two acts. Development 136(18):3033\u20133042. https:\/\/doi.org\/10.1242\/DEV.033183","journal-title":"Development"},{"issue":"5","key":"2259_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIG.2017.12.008","volume":"34","author":"AJ Song","year":"2018","unstructured":"Song AJ, Palmiter RD (2018) Detecting and avoiding problems when using the Cre\/lox system. Trends Genet 34(5):333. https:\/\/doi.org\/10.1016\/J.TIG.2017.12.008","journal-title":"Trends Genet"},{"issue":"6","key":"2259_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/0023677219856918\/ASSET\/IMAGES\/LARGE\/10.1177_0023677219856918-FIG1.JPEG","volume":"53","author":"N Ved","year":"2019","unstructured":"Ved N, Curran A, Ashcroft FM, Sparrow DB (2019) Tamoxifen administration in pregnant mice can be deleterious to both mother and embryo. Lab Anim 53(6):630\u2013633. https:\/\/doi.org\/10.1177\/0023677219856918\/ASSET\/IMAGES\/LARGE\/10.1177_0023677219856918-FIG1.JPEG","journal-title":"Lab Anim"},{"issue":"24","key":"2259_CR18","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.15252\/embj.201490332","volume":"33","author":"J Jurkin","year":"2014","unstructured":"Jurkin J, Henkel T, Nielsen AF et al (2014) The mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma cells. EMBO J 33(24):2922\u20132936. https:\/\/doi.org\/10.15252\/embj.201490332","journal-title":"EMBO J"},{"issue":"Pt 12","key":"2259_CR19","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1093\/BRAIN\/AWR274","volume":"134","author":"MAT Nguyen","year":"2011","unstructured":"Nguyen MAT, Joya JE, Kee AJ et al (2011) Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy. Brain 134(Pt 12):3513\u20133526. https:\/\/doi.org\/10.1093\/BRAIN\/AWR274","journal-title":"Brain"},{"issue":"6","key":"2259_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/J.AJPATH.2016.02.008","volume":"186","author":"J Tinklenberg","year":"2016","unstructured":"Tinklenberg J, Meng H, Yang L et al (2016) Treatment with ActRIIB-mFc produces myofiber growth and improves lifespan in the Acta1 H40Y murine model of nemaline myopathy. Am J Pathol 186(6):1568\u20131581. https:\/\/doi.org\/10.1016\/J.AJPATH.2016.02.008","journal-title":"Am J Pathol"},{"key":"2259_CR21","doi-asserted-by":"publisher","DOI":"10.21769\/BIOPROTOC.3400","author":"VV Rao","year":"2019","unstructured":"Rao VV, Mohanty A (2019) Immunohistochemical identification of muscle fiber types in mice tibialis anterior sections. Bio Protoc. https:\/\/doi.org\/10.21769\/BIOPROTOC.3400","journal-title":"Bio Protoc"},{"issue":"3","key":"2259_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/bjd.18165","volume":"182","author":"C Angwin","year":"2020","unstructured":"Angwin C, Ghali N, Baker D et al (2020) Electron microscopy in the diagnosis of Ehlers-Danlos syndromes: correlation with clinical and genetic investigations. Br J Dermatol 182(3):698\u2013707. https:\/\/doi.org\/10.1111\/bjd.18165","journal-title":"Br J Dermatol"},{"issue":"D1","key":"2259_CR23","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/NAR\/GKAC1000","volume":"51","author":"D Szklarczyk","year":"2022","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2022) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638. https:\/\/doi.org\/10.1093\/NAR\/GKAC1000","journal-title":"Nucleic Acids Res"},{"issue":"SUPPL. 1","key":"2259_CR24","doi-asserted-by":"publisher","first-page":"S751","DOI":"10.1016\/S0098-1354(99)80184-7","volume":"23","author":"MR Westerweele","year":"1999","unstructured":"Westerweele MR, Preisig HA, Weiss M (1999) Concept and design of Modeller, a computer-aided modelling tool. Comput Chem Eng 23(SUPPL. 1):S751\u2013S754. https:\/\/doi.org\/10.1016\/S0098-1354(99)80184-7","journal-title":"Comput Chem Eng"},{"issue":"8035","key":"2259_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41586-024-08044-1","volume":"634","author":"D Cao","year":"2024","unstructured":"Cao D, Bergmann J, Zhong L et al (2024) Selective utilization of glucose metabolism guides mammalian gastrulation. Nature 634(8035):919\u2013928. https:\/\/doi.org\/10.1038\/s41586-024-08044-1","journal-title":"Nature"},{"issue":"3","key":"2259_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/J.SEMCDB.2008.12.013","volume":"20","author":"R Dumollard","year":"2009","unstructured":"Dumollard R, Carroll J, Duchen MR, Campbell K, Swann K (2009) Mitochondrial function and redox state in mammalian embryos. Semin Cell Dev Biol 20(3):346\u2013353. https:\/\/doi.org\/10.1016\/J.SEMCDB.2008.12.013","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"2259_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/TOXSCI\/KFH268","volume":"82","author":"LK Rogers","year":"2004","unstructured":"Rogers LK, Tamura T, Rogers BJ, Welty SE, Hansen TN, Smith CV (2004) Analyses of glutathione reductase hypomorphic mice indicate a genetic knockout. Toxicol Sci 82(2):367\u2013373. https:\/\/doi.org\/10.1093\/TOXSCI\/KFH268","journal-title":"Toxicol Sci"},{"issue":"1","key":"2259_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/DBIO.1996.0208","volume":"178","author":"M Matsui","year":"1996","unstructured":"Matsui M, Oshima M, Oshima H et al (1996) Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 178(1):179\u2013185. https:\/\/doi.org\/10.1006\/DBIO.1996.0208","journal-title":"Dev Biol"},{"issue":"26","key":"2259_CR29","doi-asserted-by":"publisher","first-page":"14512","DOI":"10.1073\/PNAS.94.26.14512","volume":"94","author":"MT Johnson","year":"1997","unstructured":"Johnson MT, Yang HS, Magnuson T, Patel MS (1997) Targeted disruption of the murine dihydrolipoamide dehydrogenase gene (Dld) results in perigastrulation\u2009lethality. Proc Natl Acad Sci U S A 94(26):14512. https:\/\/doi.org\/10.1073\/PNAS.94.26.14512","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2259_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3349\/YMJ.2006.47.4.513","volume":"47","author":"SJ Na","year":"2006","unstructured":"Na SJ, Kim WK, Kim TS, Kang SW, Lee EY, Choi YC (2006) Comparison of clinical characteristics between congenital fiber type disproportion myopathy and congenital myopathy with type 1 fiber predominance. Yonsei Med J 47(4):513\u2013518. https:\/\/doi.org\/10.3349\/YMJ.2006.47.4.513","journal-title":"Yonsei Med J"},{"issue":"5","key":"2259_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0387-7604(86)80098-5","volume":"8","author":"T Miike","year":"1986","unstructured":"Miike T, Ohtani Y, Tamari H, Ishitsu T, Une Y (1986) Muscle fiber type transformation in nemaline myopathy and congenital fiber type disproportion. Brain Dev 8(5):526\u2013532. https:\/\/doi.org\/10.1016\/S0387-7604(86)80098-5","journal-title":"Brain Dev"},{"issue":"4","key":"2259_CR32","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1152\/PHYSREV.00031.2010","volume":"91","author":"S Schiaffino","year":"2011","unstructured":"Schiaffino S, Reggiani C (2011) Fiber types in mammalian skeletal muscles. Physiol Rev 91(4):1447\u20131531. https:\/\/doi.org\/10.1152\/PHYSREV.00031.2010","journal-title":"Physiol Rev"},{"issue":"1","key":"2259_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1152\/PHYSREV.1994.74.1.49","volume":"74","author":"RH Fitts","year":"1994","unstructured":"Fitts RH (1994) Cellular mechanisms of muscle fatigue. Physiol Rev 74(1):49\u201394. https:\/\/doi.org\/10.1152\/PHYSREV.1994.74.1.49","journal-title":"Physiol Rev"},{"issue":"1","key":"2259_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1152\/PHYSREV.00015.2007","volume":"88","author":"DG Allen","year":"2008","unstructured":"Allen DG, Lamb GD, Westerblad H (2008) Skeletal muscle fatigue: cellular mechanisms. Physiol Rev 88(1):287\u2013332. https:\/\/doi.org\/10.1152\/PHYSREV.00015.2007","journal-title":"Physiol Rev"},{"issue":"4-5","key":"2259_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/S10974-005-9013-X","volume":"26","author":"CJ Barclay","year":"2005","unstructured":"Barclay CJ (2005) Modelling diffusive O(2) supply to isolated preparations of mammalian skeletal and cardiac muscle. J Muscle Res Cell Motil 26(4\u20135):225\u2013235. https:\/\/doi.org\/10.1007\/S10974-005-9013-X","journal-title":"J Muscle Res Cell Motil"},{"issue":"6","key":"2259_CR36","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/JBMR.2177","volume":"29","author":"F Chen","year":"2014","unstructured":"Chen F, Guo R, Itoh S et al (2014) First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome. J Bone Miner Res 29(6):1412\u20131423. https:\/\/doi.org\/10.1002\/JBMR.2177","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2259_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/J.NMD.2010.12.002","volume":"21","author":"SA Novotny","year":"2011","unstructured":"Novotny SA, Warren GL, Lin AS, Guldberg RE, Baltgalvis KA, Lowe DA (2011) Bone is functionally impaired in dystrophic mice but less so than skeletal muscle. Neuromuscul Disord 21(3):183. https:\/\/doi.org\/10.1016\/J.NMD.2010.12.002","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"2259_CR38","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/JBMR.410","volume":"26","author":"A Rufo","year":"2011","unstructured":"Rufo A, Del Fattore A, Capulli M et al (2011) Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26(8):1891. https:\/\/doi.org\/10.1002\/JBMR.410","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2259_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0005-2787(72)90251-1","volume":"272","author":"BK Choe","year":"1972","unstructured":"Choe BK, Taylor MW (1972) Kinetics of synthesis and characterization of transfer RNA precursors in mammalian cells. Biochimica et Biophysica Acta Nucleic Acids Protein Synthesis 272(2):275\u2013287. https:\/\/doi.org\/10.1016\/0005-2787(72)90251-1","journal-title":"Biochimica et Biophysica Acta Nucleic Acids Protein Synthesis"},{"issue":"4","key":"2259_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1242\/DEV.052803","volume":"138","author":"N Fossat","year":"2011","unstructured":"Fossat N, Jones V, Khoo PL et al (2011) Stringent requirement of a proper level of canonical WNT signalling activity for head formation in mouse embryo. Development 138(4):667\u2013676. https:\/\/doi.org\/10.1242\/DEV.052803","journal-title":"Development"},{"issue":"2","key":"2259_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1242\/JCS.112.2.191","volume":"112","author":"F Edom-Vovard","year":"1999","unstructured":"Edom-Vovard F, Mouly V, Barbet JP, Butler-Browne GS (1999) The four populations of myoblasts involved in human limb muscle formation are present from the onset of primary myotube formation. J Cell Sci 112(2):191\u2013199. https:\/\/doi.org\/10.1242\/JCS.112.2.191","journal-title":"J Cell Sci"},{"issue":"2","key":"2259_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/humu.23938","volume":"41","author":"SJ Bryen","year":"2020","unstructured":"Bryen SJ, Ewans LJ, Pinner J et al (2020) Recurrent TTN metatranscript\u2010only c.39974\u201311T>G splice variant associated with autosomal recessive arthrogryposis multiplex congenita and myopathy. Hum Mutat 41(2):403\u2013411. https:\/\/doi.org\/10.1002\/humu.23938","journal-title":"Hum Mutat"},{"issue":"2","key":"2259_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12192-011-0306-2","volume":"17","author":"A Van Schadewijk","year":"2012","unstructured":"Van Schadewijk A, Van\u2019T Wout EFA, Stolk J, Hiemstra PS (2012) A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress. Cell Stress Chaperones 17(2):275\u2013279. https:\/\/doi.org\/10.1007\/s12192-011-0306-2","journal-title":"Cell Stress Chaperones"},{"key":"2259_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-385114-7.00004-0","volume":"490","author":"CM Oslowski","year":"2011","unstructured":"Oslowski CM, Urano F (2011) Measuring ER stress and the unfolded protein response using mammalian tissue culture system. Methods Enzymol 490:71\u201392. https:\/\/doi.org\/10.1016\/B978-0-12-385114-7.00004-0","journal-title":"Methods Enzymol"},{"key":"2259_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/S40478-022-01473-X","author":"J Yasa","year":"2023","unstructured":"Yasa J, Reed CE, Bournazos AM et al (2023) Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/S40478-022-01473-X","journal-title":"Acta Neuropathol Commun"},{"key":"2259_CR46","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1016\/j.bone.2022.116378","volume":"159","author":"LR Lee","year":"2022","unstructured":"Lee LR, Holman AE, Li X et al (2022) Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta. Bone 159:8756\u20133282. https:\/\/doi.org\/10.1016\/j.bone.2022.116378","journal-title":"Bone"},{"issue":"5","key":"2259_CR47","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/HMG\/DDV613","volume":"25","author":"MW Hogarth","year":"2016","unstructured":"Hogarth MW, Garton FC, Houweling PJ et al (2016) Analysis of the ACTN3 heterozygous genotype suggests that \u03b1-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion. Hum Mol Genet 25(5):866\u2013877. https:\/\/doi.org\/10.1093\/HMG\/DDV613","journal-title":"Hum Mol Genet"},{"key":"2259_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2021.696039","author":"L Kiriaev","year":"2021","unstructured":"Kiriaev L, Perry BD, Mahns DA et al (2021) Minocycline treatment reduces mass and force output from fast-twitch mouse muscles and inhibits myosin production in C2C12 myotubes. Front Physiol. https:\/\/doi.org\/10.3389\/FPHYS.2021.696039","journal-title":"Front Physiol"},{"issue":"6","key":"2259_CR49","doi-asserted-by":"publisher","first-page":"C662","DOI":"10.1152\/AJPCELL.00161.2017","volume":"314","author":"L Kiriaev","year":"2018","unstructured":"Kiriaev L, Kueh S, Morley JW, North KN, Houweling PJ, Head SI (2018) Branched fibers from old fast-twitch dystrophic muscles are the sites of terminal damage in muscular dystrophy. Am J Physiol Cell Physiol 314(6):C662\u2013C674. https:\/\/doi.org\/10.1152\/AJPCELL.00161.2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"2259_CR50","doi-asserted-by":"publisher","first-page":"C704","DOI":"10.1152\/AJPCELL.00122.2021","volume":"321","author":"L Kiriaev","year":"2021","unstructured":"Kiriaev L, Kueh S, Morley JW et al (2021) Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the mdx mouse. Am J Physiol Cell Physiol 321(4):C704\u2013C720. https:\/\/doi.org\/10.1152\/AJPCELL.00122.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"2259_CR51","doi-asserted-by":"publisher","DOI":"10.1152\/AJPCELL.1998.274.4.C1138","author":"A Hayes","year":"1998","unstructured":"Hayes A, Williams DA (1998) Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice. Am J Physiol. https:\/\/doi.org\/10.1152\/AJPCELL.1998.274.4.C1138","journal-title":"Am J Physiol"},{"key":"2259_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/J.EBIOM.2024.105156","author":"E Tsang","year":"2024","unstructured":"Tsang E, Han VX, Flutter C et al (2024) Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome. EBioMedicine. https:\/\/doi.org\/10.1016\/J.EBIOM.2024.105156","journal-title":"EBioMedicine"},{"issue":"12","key":"2259_CR53","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/NPROT.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J (2016) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11(12):2301\u20132319. https:\/\/doi.org\/10.1038\/NPROT.2016.136","journal-title":"Nat Protoc"},{"key":"2259_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.3000170","author":"K Engholm-Keller","year":"2019","unstructured":"Engholm-Keller K, Waardenberg AJ, M\u00fcller JA et al (2019) The temporal profile of activity-dependent presynaptic phospho-signalling reveals long-lasting patterns of poststimulus regulation. PLoS Biol. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3000170","journal-title":"PLoS Biol"},{"issue":"7","key":"2259_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKV007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/NAR\/GKV007","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2259_CR56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/BIOSTATISTICS\/KXR034","volume":"13","author":"JA Gagnon-Bartsch","year":"2012","unstructured":"Gagnon-Bartsch JA, Speed TP (2012) Using control genes to correct for unwanted variation in microarray data. Biostatistics 13(3):539\u2013552. https:\/\/doi.org\/10.1093\/BIOSTATISTICS\/KXR034","journal-title":"Biostatistics"},{"issue":"12","key":"2259_CR57","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1093\/NAR\/GKZ433","volume":"47","author":"R Molania","year":"2019","unstructured":"Molania R, Gagnon-Bartsch JA, Dobrovic A, Speed TP (2019) A new normalization for Nanostring nCounter gene expression data. Nucleic Acids Res 47(12):6073\u20136083. https:\/\/doi.org\/10.1093\/NAR\/GKZ433","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2259_CR58","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/BIOINFORMATICS\/BTP053","volume":"25","author":"DJ Mccarthy","year":"2009","unstructured":"Mccarthy DJ, Smyth GK (2009) Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 25(6):765\u2013771. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTP053","journal-title":"Bioinformatics"},{"key":"2259_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/J.XINN.2021.100141\/ATTACHMENT\/19F0A0E0-397E-4A0C-8995-02608B6642C2\/MMC2.PDF","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S et al (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. https:\/\/doi.org\/10.1016\/J.XINN.2021.100141\/ATTACHMENT\/19F0A0E0-397E-4A0C-8995-02608B6642C2\/MMC2.PDF","journal-title":"Innovation"},{"issue":"5","key":"2259_CR60","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/NAR\/GKH340","volume":"32","author":"RC Edgar","year":"2004","unstructured":"Edgar RC (2004) Muscle: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32(5):1792\u20131797. https:\/\/doi.org\/10.1093\/NAR\/GKH340","journal-title":"Nucleic Acids Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02259-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:11:29Z","timestamp":1781637089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02259-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02259-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse work in this study was performed under the approval of the Children\u2019s Hospital at Westmead\/Children\u2019s Medical Research Institute Animal Ethics approval K380 and the Western Sydney Local Health Animal Ethics approval 4364.02.20 \u2013 Modelling human PYROXD1 myopathy and Murdoch Children\u2019s Research Institute approval A969. Principles of laboratory animal care (NIH publication No. 86\u201323, revised 1985) were followed, as well as specific Australian animal welfare laws where applicable. Human muscle biopsies were obtained under Ethics approval by the Children\u2019s Hospital at Westmead Human Research Ethics Committee (Biospecimen Bank_10\/CHW\/ 45 and 2019\/ETH11736) with informed, written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.T.C is volunteer member of ClinGen Expert Panels: Muscular Dystrophies and Myopathies GCEP and Limb Girdle Muscular Dystrophy VCEP. S.T.C is named Inventor of Intellectual Property (IP) relating to novel methods to identify splicing variants, at varying stages of review by International Patent Offices. 1) WO2020097660A1. Inventors S. Cooper and H. Joshi. 2) WO2020\/181333. Inventor S. Cooper. This IP is owned jointly by The University of Sydney and Sydney Children\u2019s Hospitals Network. S.T.C is Director of Frontier Genomics Pty Australia which has licenced this IP and is commercialising GENEie. S.T.C currently receives no remuneration or consultancy fees for this role. No other authors have relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}